 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ICON Public (NASDAQ:ICLR - Free Report) had its target price raised by Robert W. Baird from $345.00 to $362.00 in a research report sent to investors on Thursday, Benzinga reports. Robert W. Baird...

Robert W. Baird Boosts ICON Public (NASDAQ:ICLR) Price Target to $362.00

ICON Public (NASDAQ:ICLR - Get Free Report)s stock had its "buy" rating restated by equities research analysts at Mizuho in a report issued on Thursday, Benzinga reports. They presently have a...

ICON Public (NASDAQ:ICLR) Earns "Buy" Rating from Mizuho

ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in...

ICON Announces CFO Transition

TimesSquare Capital Management, an equity investment management company, released its U.S. Mid Cap Growth Strategy fourth-quarter investor letter. A copy of the same can be downloaded here. In the...

ICON Public Limited Company (ICLR) Improved by 15% in Q4

ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2024 after the...

ICON plc Schedules First Quarter 2024 Earnings Conference Call

Shares of ICON Public Limited (NASDAQ:ICLR  Get Free Report) have been assigned a consensus rating of Buy from the eight brokerages that are currently covering the stock...

Analysts Set ICON Public Limited (NASDAQ:ICLR) Price Target at $312.64

TimesSquare Capital Management LLC cut its holdings in shares of ICON Public Limited (NASDAQ:ICLR  Free Report) by 4.9% in the third quarter, according to its most recent filing with the...

ICON Public Limited (NASDAQ:ICLR) Shares Sold by TimesSquare Capital Management LLC

ICON Public (NASDAQ:ICLR  Free Report) had its price target lifted by Mizuho from $315.00 to $346.00 in a research report report published on Friday morning, Benzinga reports. The brokerage...

ICON Public (NASDAQ:ICLR) Price Target Raised to $346.00

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the TD Cowen...

ICON plc to Present at Upcoming Investor Conferences

ICON Public (NASDAQ:ICLR  Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $14.50-$15.30 for the period, compared to...

ICON Public (NASDAQ:ICLR) Updates FY24 Earnings Guidance

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Volume (M)	496,031.00
52-Wk High	$344.77
52-Wk Low	$181.92

ICLR Icon Plc

About

Feed

News

Sentiment

Earnings

Fundamentals